Anchor Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$435K Hold
1,235
0.01% 205
2025
Q4
$404K Hold
1,235
0.01% 218
2025
Q3
$349K Hold
1,235
0.01% 220
2025
Q2
$345K Hold
1,235
0.01% 218
2025
Q1
$385K Hold
1,235
0.01% 212
2024
Q4
$322K Hold
1,235
0.01% 225
2024
Q3
$398K Hold
1,235
0.01% 207
2024
Q2
$386K Hold
1,235
0.01% 208
2024
Q1
$351K Hold
1,235
0.01% 220
2023
Q4
$356K Hold
1,235
0.01% 213
2023
Q3
$332K Hold
1,235
0.01% 231
2023
Q2
$274K Hold
1,235
0.01% 243
2023
Q1
$299K Hold
1,235
0.01% 236
2022
Q4
$324K Hold
1,235
0.01% 234
2022
Q3
$278K Hold
1,235
0.01% 241
2022
Q2
$300K Sell
1,235
-177
-13% -$43.4K 0.01% 242
2022
Q1
$341K Buy
1,412
+177
+14% +$40.7K 0.01% 238
2021
Q4
$278K Hold
1,235
0.01% 252
2021
Q3
$263K Hold
1,235
0.01% 248
2021
Q2
$301K Sell
1,235
-2,800
-69% -$689K 0.01% 245
2021
Q1
$1M Sell
4,035
-50
-1% -$11.9K 0.02% 180
2020
Q4
$939K Hold
4,085
0.02% 183
2020
Q3
$1.04M Sell
4,085
-200
-5% -$49.5K 0.03% 161
2020
Q2
$1.01M Hold
4,285
0.03% 159
2020
Q1
$869K Hold
4,285
0.03% 156
2019
Q4
$1.03M Sell
4,285
-78
-2% -$17.2K 0.02% 160
2019
Q3
$844K Buy
4,363
+478
+12% +$91.8K 0.03% 174
2019
Q2
$716K Hold
3,885
0.03% 176
2019
Q1
$738 Hold
3,885
0.02% 173
2018
Q4
$756K Hold
3,885
0.03% 190
2018
Q3
$805K Sell
3,885
-50
-1% -$9.85K 0.03% 189
2018
Q2
$726K Buy
+3,935
New +$696K 0.03% 200
2018
Q1
Sell
-1,975
Closed -$343K 305
2017
Q4
$343K Hold
1,975
0.01% 232
2017
Q3
$368K Hold
1,975
0.01% 221
2017
Q2
$340K Sell
1,975
-1,842
-48% -$300K 0.01% 227
2017
Q1
$626K Sell
3,817
-848
-18% -$141K 0.02% 201
2016
Q4
$682K Sell
4,665
-118,325
-96% -$17.8M 0.03% 190
2016
Q3
$20.5M Sell
122,990
-43,848
-26% -$7.41M 0.69% 60
2016
Q2
$25.4M Sell
166,838
-59,556
-26% -$9.26M 0.64% 65
2016
Q1
$33.9M Sell
226,394
-3,162
-1% -$470K 0.81% 51
2015
Q4
$37.3M Sell
229,556
-2,685
-1% -$422K 0.94% 41
2015
Q3
$32.1M Sell
232,241
-6,857
-3% -$1.08M 0.82% 52
2015
Q2
$36.7M Sell
239,098
-2,821
-1% -$452K 0.83% 51
2015
Q1
$38.7M Sell
241,919
-20,075
-8% -$3.16M 0.84% 47
2014
Q4
$41.7M Sell
261,994
-2,498
-0.9% -$389K 0.84% 47
2014
Q3
$37.2M Sell
264,492
-409
-0.2% -$53.4K 0.77% 51
2014
Q2
$31.4M Buy
264,901
+17,052
+7% +$1.97M 0.6% 69
2014
Q1
$30.6M Sell
247,849
-466
-0.2% -$56.5K 0.61% 66
2013
Q4
$28.3M Buy
248,315
+33,222
+15% +$3.78M 0.56% 68
2013
Q3
$24.1M Buy
215,093
+1,303
+0.6% +$141K 0.52% 71
2013
Q2
$21.1M Buy
+213,790
New +$22.2M 0.45% 69

Other funds holding AMGN

Anchor Capital Advisors's AMGN Position: Q1 2026 in Review

Anchor Capital Advisors held its Amgen (AMGN) position steady in Q1 2026 at 1,235 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #205.

Anchor Capital Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $41.7M in Q4 2014. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Anchor Capital Advisors held 1,235 shares of Amgen worth $435K as of Q1 2026.
  • Anchor Capital Advisors left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.01% of Anchor Capital Advisors's portfolio in Q1 2026, its #205 holding.
  • Anchor Capital Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Anchor Capital Advisors's Amgen position peaked at $41.7M in Q4 2014.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Anchor Capital Advisors's 13F filing for Q1 2026, filed 12 May 2026.